Gilead Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Gilead Sciences generated cash of $8,006,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$5,125,000,000 last year. Net change in cash is therefore $673,000,000.
Cash Flow
| 2014 | 12.81B | -1.82B | -3.02B |
|---|---|---|---|
| 2015 | 20.32B | -12.47B | -4.96B |
| 2016 | 16.66B | -11.98B | -9.34B |
| 2017 | 11.89B | -16.06B | 3.39B |
| 2018 | 8.4B | 14.35B | -12.31B |
| 2019 | 9.14B | -7.81B | -7.63B |
| 2020 | 8.16B | -14.61B | 770M |
| 2021 | 11.38B | -3.13B | -8.87B |
| 2022 | 9.07B | -2.46B | -6.46B |
| 2023 | 8.00B | -2.26B | -5.12B |
GILD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.41B | 5.33B | 5.99B | 11.63B | 17.94B | 7.58B | 8.22B | 12.85B | 10.02B | 2.11B |
Operating activities | ||||||||||
Net income | 5.61B | 4.56B | 6.20B | 89M | 5.36B | 5.46B | 4.64B | 13.48B | 18.10B | 12.05B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.69B | 2.10B | 2.05B | 1.48B | 1.40B | 1.42B | 1.28B | 1.15B | 1.09B | 1.05B |
Stock-based compensation expense | 795M | 637M | 635M | 643M | 636M | 845M | 638M | 380M | 382M | 360M |
| Deferred income tax benefit | 795M | 637M | 635M | 643M | 636M | 845M | 638M | 380M | 382M | 360M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 157M | -406M | 313M | -1.17B | -218M | 480M | 754M | 1.19B | -1.39B | -2.57B |
Inventories | -842M | -310M | 11M | -195M | -95M | -310M | -253M | -488M | -855M | 143M |
Accounts payable | -347M | 226M | -118M | 80M | -61M | -39M | -430M | 47M | 226M | -289M |
Cash generated by operating activities | 8.00B | 9.07B | 11.38B | 8.16B | 9.14B | 8.4B | 11.89B | 16.66B | 20.32B | 12.81B |
Investing activities | ||||||||||
Purchases Of Investments | -2.37B | -1.94B | -3.89B | -20.77B | -32.22B | -10.57B | -23.31B | -25.97B | -17.23B | -2.12B |
Investments In Property Plant And Equipment | -585M | -728M | -579M | -650M | -825M | -924M | -590M | -748M | -747M | -557M |
Acquisitions Net | -1.15B | -1.79B | -1.40B | -25.74B | 825M | 346M | -10.42B | 357M | 0 | 18M |
Cash generated by investing activities | -2.26B | -2.46B | -3.13B | -14.61B | -7.81B | 14.35B | -16.06B | -11.98B | -12.47B | -1.82B |
Financing activities | ||||||||||
Common Stock Issued | 232M | 309M | 169M | 256M | 209M | 289M | 234M | 208M | 319M | 331M |
Payments for dividends | -3.80B | -3.70B | -3.60B | -3.44B | -3.22B | -2.97B | -2.73B | -2.45B | -1.87B | 0 |
Repurchases of common stock | -1B | -1.39B | -546M | -1.58B | -1.74B | -2.9B | -954M | -11.00B | -10.00B | -5.34B |
Repayments of term debt | -270M | -1.5B | -4.75B | -2.5B | -2.75B | -6.25B | 7.17B | -1.98B | 9.68B | -4.80B |
Cash used in financing activities | -5.12B | -6.46B | -8.87B | 770M | -7.63B | -12.31B | 3.39B | -9.34B | -4.96B | -3.02B |
Net Change In Cash | 673M | 74M | -659M | -5.63B | -6.30B | 10.35B | -641M | -4.62B | 2.82B | 7.91B |
Cash at end of period | 6.08B | 5.41B | 5.33B | 5.99B | 11.63B | 17.94B | 7.58B | 8.22B | 12.85B | 10.02B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |